Oficinas Centrales
2300 Riverchase Center
Birmingham, AL 35244

tel.: 888.246.8338
tel.: 205.967.7880
fax: 205.870.0304

BioHorizons Canada
21 Amber Street, Unit #6
Markham, Ontario L3R 4Z3

tel.: 866.468.8338
fax: 905.944.1894

BioHorizons Chile, S.A.
Av. Manquehue Norte 1337 Of. 31

tel.: +56 (2) 23619519
fax: +56 (2) 361.9521

BioHorizons Camlog Italia
Via Ettore Cristoni, 88
40033 Casalecchio di Reno (BO) Italia

numero verde +800.063.040
tel. +
fax +

BioHorizons Mexico
Cracovia No. 72 Torre B, Oficina: BGO-07, Col. San Ángel
CP: 01000, Ciudad de México, Álvaro Obregón, CDMX

tel. 800 953 0498

BioHorizons Camlog Ibérica
BioHorizons España
Calle Oruro, 9
Madrid, 28016

tel.: +34.91.713.10.84
fax: +34.91.355.83.75

BioHorizons UK
Richmond House
Oldbury Road
Berkshire RG12 8TQ
Reino Unido

tel.: +44 (0)1344 752560
fax: +44 (0)1344 868049

IntraSpin® system



The IntraSpin® system is designed with a simple three-step protocol which includes drawing and spinning the patients' blood, removing the fibrin clot and processing it in the Xpression® fabrication kit.

No anticoagulant, bovine thrombin, heating, pipetting, second spin, chemical additives or expensive consumables

Sistema IntraSpin


The IntraSpin® system is an FDA-cleared medical device for the production of Leukocyte- and Platelet Rich Fibrin (L-PRF). It has been reported as the most stable centrifuge and offers up to 80% reduction in undesirable vibrations.1 The IntraSpin system utilizes a simplified chairside procedure which results in the production of a thin, compressed layer of Leukocyte- and Platelet-Rich Fibrin that is strong, pliable and suitable for suturing. This natural fibrin network is rich in platelets, growth factors, cytokines and leukocytes.2 The presence of these proteins has been reported to produce rapid healing, especially during the critical first seven days after placement.3


  • bone defects
  • alveolos post-extracción
  • sinus & dental ridge augmentation
  • palatal defects
  • maxillary bone atrophy
IntraSpin prf


  1. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane, Platelets
    Ehrenfest David M. Dohan , Pinto Nelson R., Pereda Andrea, Jiménez Paula, Del Corso Marco, Kang Byung-Soo, Nally Mauricio, Lanata Nicole, Wang Hom-Lay, Quirynen Marc. (2017), DOI: 10.1080/09537104.2017.1293812
  2. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane.
    Dohan Ehrenfest DM. Del Corso M, Diss A, et al. J Periodontal. 2010 Apr;81(4):546-55
  3. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies
    Dohan Ehrenfest, David M.; de Peppo, Giuseppe; Doglioli Pierre; Sammartino Gilberto. Factores de crecimiento. Volumen 27, número 1. Febrero de 2009, pp. 63-69(7)
  4. Reference manufacturer's Instructions for Use (IFU) package insert.
No disponible en todos los países.